Zhihao Wei

1.5k total citations
38 papers, 646 citations indexed

About

Zhihao Wei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Zhihao Wei has authored 38 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Zhihao Wei's work include Ferroptosis and cancer prognosis (8 papers), Catalytic Processes in Materials Science (5 papers) and Epigenetics and DNA Methylation (5 papers). Zhihao Wei is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Catalytic Processes in Materials Science (5 papers) and Epigenetics and DNA Methylation (5 papers). Zhihao Wei collaborates with scholars based in China, Finland and United Kingdom. Zhihao Wei's co-authors include Liuyang Zhang, Jiaguo Yu, S. Wageh, Pengfei Cai, Ahmed A. Al‐Ghamdi, Xiaoping Zhang, Xiaohui Pu, Lanlan Zong, Juanjuan Shan and Cheng Qian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cancer Cell.

In The Last Decade

Zhihao Wei

33 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihao Wei China 13 209 176 172 166 114 38 646
Tianliang Ma China 15 127 0.6× 86 0.5× 286 1.7× 263 1.6× 104 0.9× 35 945
Xiao‐Li Yang China 17 63 0.3× 251 1.4× 278 1.6× 249 1.5× 157 1.4× 54 1.0k
Guangjie Yang China 14 180 0.9× 130 0.7× 76 0.4× 229 1.4× 32 0.3× 43 821
Chunyan Zeng China 16 69 0.3× 228 1.3× 263 1.5× 201 1.2× 48 0.4× 55 797
Mengbin Li China 15 96 0.5× 60 0.3× 78 0.5× 178 1.1× 140 1.2× 26 574
Seul Lee South Korea 14 106 0.5× 286 1.6× 89 0.5× 322 1.9× 104 0.9× 41 845
Xiaohu Gu China 15 82 0.4× 74 0.4× 189 1.1× 195 1.2× 58 0.5× 22 548
Sipeng Guo China 7 153 0.7× 117 0.7× 71 0.4× 84 0.5× 37 0.3× 9 489
Zixin Wu China 13 84 0.4× 393 2.2× 134 0.8× 186 1.1× 74 0.6× 42 904

Countries citing papers authored by Zhihao Wei

Since Specialization
Citations

This map shows the geographic impact of Zhihao Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihao Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihao Wei more than expected).

Fields of papers citing papers by Zhihao Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihao Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihao Wei. The network helps show where Zhihao Wei may publish in the future.

Co-authorship network of co-authors of Zhihao Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihao Wei. A scholar is included among the top collaborators of Zhihao Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihao Wei. Zhihao Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Yi, Jiaqi Liu, Zhihao Wei, et al.. (2025). Exploring the mechanisms of torularhodin in alleviating diabetic kidney disease: a microbiome and metabolomics approach through the gut-kidney axis. Food Research International. 221(Pt 4). 117597–117597.
3.
Zhao, Xiang, Yijie Wang, Rui Zhang, et al.. (2025). Metabolic‐Immune Suppression Mediated by the SIRT1‐CX3CL1 Axis Induces Functional Enhancement of Regulatory T Cells in Colorectal Carcinoma. Advanced Science. 12(17). e2404734–e2404734. 7 indexed citations
4.
Wei, Zhihao, Chenchen Liu, Jiaqian Liang, et al.. (2024). Characterization of Mitoribosomal Small Subunit unit genes related immune and pharmacogenomic landscapes in renal cell carcinoma. IUBMB Life. 76(9). 647–665. 1 indexed citations
5.
Su, Junjie, Ruixin Li, Haojie Wang, et al.. (2024). Prognostic and therapeutic model based on disulfidptosis-related genes for patients with clear cell renal cell carcinoma. Heliyon. 10(11). e32258–e32258.
6.
Yuan, Yuheng, Bin Guan, Junyan Chen, et al.. (2024). Research status and outlook of molecular sieve NH3-SCR catalysts. Molecular Catalysis. 554. 113846–113846. 17 indexed citations
7.
Xin, Shiyong, Junjie Su, Ruixin Li, et al.. (2024). Identification of a risk model for prognostic and therapeutic prediction in renal cell carcinoma based on infiltrating M0 cells. Scientific Reports. 14(1). 13390–13390. 3 indexed citations
8.
Hu, Xuehan, Bin Guan, Junyan Chen, et al.. (2024). Research status and advances of catalysts for hydrogen production from ammonia decomposition: Refined regulation methods. Fuel. 381. 133134–133134. 6 indexed citations
9.
Li, Yihong, Min Huang, Yi Wang, et al.. (2024). Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite. Cancer Cell. 42(6). 985–1002.e18. 25 indexed citations
10.
Zhang, Yanwei, Zhenhua Zhang, Ziyao Li, et al.. (2024). ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma. Cancer Gene Therapy. 31(8). 1201–1220.
11.
12.
Guan, Bin, Jiangfeng Guo, Junyan Chen, et al.. (2023). Review of the Catalytic System, Synthetic Process, and Support Morphological Research in Selective Catalytic Oxidation of Ammonia. Industrial & Engineering Chemistry Research. 62(48). 20506–20546. 10 indexed citations
13.
Li, Ruixin, Junjie Su, Haojie Wang, et al.. (2023). A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma. Journal of Cancer Research and Clinical Oncology. 149(15). 13925–13942. 6 indexed citations
14.
Liu, Hongchao, et al.. (2023). TGF-β based risk model to predict the prognosis and immune features in glioblastoma. Frontiers in Neurology. 14. 1188383–1188383. 3 indexed citations
15.
Wang, Qi, Su Gao, Zhihao Wei, et al.. (2023). AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis. International Journal of Biological Sciences. 19(4). 1266–1283. 43 indexed citations
16.
Wang, Haojie, He Zhang, Fei Wang, et al.. (2023). Diagnostic markers and potential therapeutic agents for Sjögren’s syndrome screened through multiple machine learning and molecular docking. Clinical & Experimental Immunology. 212(3). 224–238. 6 indexed citations
17.
Wei, Zhihao, Jiatao Li, Juanjuan Shan, et al.. (2023). SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma. International Journal of Biological Sciences. 19(6). 1925–1940. 31 indexed citations
18.
Zheng, Yongqiang, Jiayuan Chen, Zhihao Wei, et al.. (2022). Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study. International Journal of Surgery. 103. 106693–106693. 6 indexed citations
19.
Wei, Zhihao, et al.. (2022). A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma. Frontiers in Genetics. 13. 894736–894736. 12 indexed citations
20.
Zong, Lanlan, Xiaohua Li, Haiyan Wang, et al.. (2017). Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(β-Benzyl- l -aspartate) (PEG-PBLA). International Journal of Pharmaceutics. 531(1). 108–117. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026